Kad\u0131nlarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrlerinden biri olan serviks kanseri, d\u00fcnya genelinde y\u00fcz binlerce kad\u0131n\u0131 etkileyen ciddi bir sa\u011fl\u0131k sorunudur. Bu hastal\u0131k \u00f6zellikle d\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde daha yayg\u0131n g\u00f6r\u00fclmekte olup, bu b\u00f6lgelerde etkili tedaviye eri\u015fim s\u0131n\u0131rl\u0131 kalmaktad\u0131r. Geleneksel tedavi se\u00e7enekleri aras\u0131nda cerrahi operasyonlar, kemoterapi ve radyoterapi yer al\u0131rken, hastal\u0131\u011f\u0131n ilerlemesi ve beraberinde ortaya \u00e7\u0131kan a\u011fr\u0131 y\u00f6netimi klinisyenler i\u00e7in hala karma\u015f\u0131k bir meydan okumad\u0131r. T\u00fcm\u00f6r\u00fcn tekrarlamas\u0131 ve \u00e7evre dokulara yay\u0131lmas\u0131 nedeniyle olu\u015fan \u015fiddetli a\u011fr\u0131, hastalar\u0131n ya\u015fam kalitesini ciddi anlamda d\u00fc\u015f\u00fcrmektedir. Ayr\u0131ca opioid bazl\u0131 a\u011fr\u0131 kesicilerin yan etkileri ve k\u00f6t\u00fcye kullan\u0131m potansiyeli nedeniyle alternatif tedavi y\u00f6ntemlerine y\u00f6nelik ara\u015ft\u0131rmalar artmaktad\u0131r. Bu ba\u011flamda, k\u00f6k h\u00fccrelerden geli\u015fen yeni yakla\u015f\u0131mlar ve hedefe y\u00f6nelik tedaviler, hem t\u00fcm\u00f6r b\u00fcy\u00fcmesini engellemek hem de a\u011fr\u0131 kontrol\u00fcn\u00fc sa\u011flamak ad\u0131na umut vadeden se\u00e7enekler aras\u0131nda yer almaktad\u0131r.<\/p>\n
Son geli\u015fmeler \u0131\u015f\u0131\u011f\u0131nda, bitkisel kaynakl\u0131 kannabinoidler olan cannabidiol (CBD) ve delta-9-tetrahidrokanabinol (THC) dikkat \u00e7ekici terap\u00f6tik potansiyelleriyle ara\u015ft\u0131r\u0131lmaktad\u0131r. G\u00fcney Afrika\u2019daki Wits Advanced Drug Delivery Platform (WADDP) Ara\u015ft\u0131rma Birimi taraf\u0131ndan haz\u0131rlanan kapsaml\u0131 bir derleme, bu bitkisel bile\u015fiklerin hem analjezik (a\u011fr\u0131 kesici) hem de antineoplastik (t\u00fcm\u00f6r\u00fc engelleyici) \u00f6zelliklerine vurgu yapmaktad\u0131r. CBD ve THC, kanser h\u00fccrelerini \u00e7evreleyen ve t\u00fcm\u00f6r\u00fcn sinir a\u011f\u0131 ile ba\u011flanan CB1, CB2, GPR55, GPR18 ve TRPV1 gibi \u00e7ok say\u0131da resept\u00f6r\u00fc etkileyerek kalsiyum iyonlar\u0131n\u0131n h\u00fccre i\u00e7ine giri\u015fini mod\u00fcle eder. Bu mekanizma sayesinde a\u011fr\u0131 sinyallerinin iletimi azal\u0131r ve opioid tedavilerinde s\u0131k\u00e7a kar\u015f\u0131la\u015f\u0131lan solunum depresyonu gibi riskler ortadan kalkar. THC\u2019nin psikoaktif etkileri klinik kullan\u0131m\u0131n\u0131 s\u0131n\u0131rland\u0131r\u0131rken, CBD\u2019nin g\u00fcvenlik profili daha elveri\u015fli olup, preklinik ara\u015ft\u0131rmalarda t\u00fcm\u00f6r geli\u015fimini bask\u0131lad\u0131\u011f\u0131 g\u00f6zlemlenmi\u015ftir. Bu nedenle CBD, klinik uygulamaya y\u00f6nelik umut vaadeden bir aday olarak \u00f6ne \u00e7\u0131kmaktad\u0131r.<\/p>\n
Kanser geli\u015fimi i\u00e7in temel s\u00fcre\u00e7lerden biri olan anjiyogenez, yani yeni kan damarlar\u0131n\u0131n olu\u015fturulmas\u0131, serviks kanserinde t\u00fcm\u00f6rlerin b\u00fcy\u00fcmesi ve yay\u0131lanmas\u0131 i\u00e7in kritik \u00f6neme sahiptir. Bu anjiyogenez s\u00fcrecini hedef alan tedaviler \u00f6zellikle vask\u00fcler endotelyal b\u00fcy\u00fcme fakt\u00f6r\u00fc (VEGF) eksenine odaklanmaktad\u0131r. Bu ba\u011flamda, VEGF-A\u2019ya ba\u011flanarak etkisini engelleyen monoklonal antikor bevacizumab, ileri evre serviks kanseri tedavisinde standart uygulamalardan biri haline gelmi\u015ftir. Klinik \u00e7al\u0131\u015fmalarda bevacizumab\u0131n kemoterapi ile kombinasyon halinde kullan\u0131lmas\u0131, hastalar\u0131n sa\u011fkal\u0131m s\u00fcrelerini anlaml\u0131 bi\u00e7imde uzatm\u0131\u015ft\u0131r. \u00d6rne\u011fin, faz II bir \u00e7al\u0131\u015fmada hastalar\u0131n hastal\u0131ks\u0131z ya\u015fam s\u00fcreleri ortalama 3.4 ay olarak raporlanm\u0131\u015f; devam eden faz III ara\u015ft\u0131rmalarda ise bevacizumab ile kemoterapi kombinasyonunun, sadece kemoterapiye k\u0131yasla genel sa\u011fkal\u0131m\u0131 3 ay kadar iyile\u015ftirdi\u011fi belirlenmi\u015ftir. Ayr\u0131ca, VEGF resept\u00f6r\u00fc tip 2 (VEGFR-2) hedefleyen apatinib ve sorafenib gibi k\u00fc\u00e7\u00fck molek\u00fcl tirozin kinaz inhibit\u00f6rleri, t\u00fcm\u00f6r vask\u00fclerizasyonunu bask\u0131lamak ad\u0131na tamamlay\u0131c\u0131 tedavi se\u00e7enekleri olarak geli\u015ftirilmektedir.<\/p>\n
Anjiyogenez inhibisyonunun yan\u0131nda, peptid bazl\u0131 yenilik\u00e7i terapilerin serviks kanserinde tedaviye katk\u0131s\u0131 giderek artmaktad\u0131r. K\u0131sa zincirli amino asitlerden olu\u015fan peptidler, kanser h\u00fccresine \u00f6zg\u00fc molek\u00fcler resept\u00f6rleri ve proliferasyon yollar\u0131n\u0131 hedefleyerek y\u00fcksek \u00f6zg\u00fcll\u00fckle h\u00fccreleri y\u00f6nlendirme ve ila\u00e7 ta\u015f\u0131mada kullan\u0131lmaktad\u0131r. H\u00fccre i\u00e7ine ge\u00e7i\u015fi kolayla\u015ft\u0131ran peptidler ve t\u00fcm\u00f6r hedefleyen peptidler, neoplastik h\u00fccrelerde se\u00e7ici ila\u00e7 al\u0131m\u0131n\u0131 art\u0131rmakta, b\u00f6ylece tedavi yerelle\u015ftirilmektedir. Ayr\u0131ca, kendi kendini organize eden peptidler nanoyap\u0131lar olu\u015fturur; bu yap\u0131lar nanofiber, k\u00fcre, t\u00fcp ve hidrojel gibi \u00e7e\u015fitli bi\u00e7imlerde olup, kimyasal veya fiziksel uyar\u0131larla (pH de\u011fi\u015fimi, enzimatik aktivite gibi) aktive olan ta\u015f\u0131y\u0131c\u0131 sistemler olarak i\u015flev g\u00f6r\u00fcr. Bu nanoyap\u0131lar sayesinde kemoterapi, gen terapisi ya da fototerapi ajanlar\u0131n\u0131n kontroll\u00fc sal\u0131n\u0131m\u0131 sa\u011flan\u0131r, ilac\u0131n kararl\u0131l\u0131\u011f\u0131 artar ve hedef b\u00f6lgedeki sal\u0131n\u0131m \u00f6zelle\u015ftirilebilir hale gelir.<\/p>\n
Nanoteknoloji alan\u0131nda geli\u015ftirilen ta\u015f\u0131y\u0131c\u0131 sistemler de serviks kanseri tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7maktad\u0131r. Bu sistemler, ilac\u0131 do\u011frudan t\u00fcm\u00f6r b\u00f6lgesine hedefleyerek sistemik yan etkileri azaltabilir. \u00d6zellikle t\u00fcm\u00f6r mikro\u00e7evresine duyarl\u0131 olarak tasarlanm\u0131\u015f nanolojik platformlar, asidik ortamda par\u00e7alanabilen konjugatlar, furin enzimi ile aktive olan lipozomlar, metal-organik \u00e7er\u00e7eve (MOF) kompozitleri, mezo-por\u00f6z silika nanopartik\u00fclleri ve Mn\u2083O\u2084 nanokompozitleri gibi farkl\u0131 yap\u0131lar, t\u00fcm\u00f6r\u00fcn asidik, enzimatik ve oksidatif ortam\u0131nda kontroll\u00fc ila\u00e7 b\u0131rak\u0131m\u0131 sa\u011flamaktad\u0131r. Bu t\u00fcr ak\u0131ll\u0131 sal\u0131m mekanizmalar\u0131 kemoterapi, radyoterapi, fototerapi ve imm\u00fcnoterapi gibi \u00e7ok modlu tedavilerin koordine edilmesine olanak tan\u0131yarak, antit\u00fcm\u00f6r etkinli\u011fin art\u0131r\u0131lmas\u0131n\u0131 ve sa\u011fl\u0131kl\u0131 dokular\u0131n korunmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131lar.<\/p>\n
Serviks kanserinde a\u011fr\u0131n\u0131n etkin y\u00f6netimi ise hala \u00f6nemli bir klinik sorun olmaya devam etmektedir. Rahim a\u011fz\u0131n\u0131n anatomik karma\u015f\u0131kl\u0131\u011f\u0131 ve t\u00fcm\u00f6r\u00fcn \u00e7evre dokuya yay\u0131lmas\u0131yla ortaya \u00e7\u0131kan hem nosiseptif hem de n\u00f6ropatik a\u011fr\u0131lar, klasik analjeziklere s\u0131kl\u0131kla diren\u00e7lidir. Bu nedenle bitkisel kaynakl\u0131 kannabinoidlerin entegre kullan\u0131m\u0131 dikkat \u00e7ekici bir yakla\u015f\u0131m sunar. Kannabinoidler, periferik ve santral a\u011fr\u0131 yolaklar\u0131na y\u00f6nelik spesifik hedeflere etki ederek opioid kullan\u0131m\u0131na ba\u011fl\u0131 riskleri azaltmakta; preklinik modellerde G proteinine ba\u011fl\u0131 resept\u00f6rler ve ge\u00e7ici resept\u00f6r potansiyel (TRP) kanallar\u0131n\u0131n analjezik etkideki rolleri a\u00e7\u0131klanmaktad\u0131r. Bu geli\u015fmeler, kanser hastalar\u0131nda opioid d\u0131\u015f\u0131 a\u011fr\u0131 kesici ila\u00e7 geli\u015ftirme s\u00fcrecine mekanistik temel sa\u011flamaktad\u0131r.<\/p>\n
Buna ra\u011fmen, bu yenilik\u00e7i tedavilerin klinik uygulamaya ge\u00e7irilmesi zorluklarla kar\u015f\u0131la\u015fmaktad\u0131r. Peptid temelli terapilerin in vivo stabilitesi, imm\u00fcnojenisite riski ve \u00fcretim s\u00fcre\u00e7lerinin \u00f6l\u00e7eklendirilmesi gibi teknik problemler bulunmaktad\u0131r. Ayr\u0131ca nanota\u015f\u0131y\u0131c\u0131lar\u0131n v\u00fccutta monon\u00fckleer fagosit sistemi taraf\u0131ndan temizlenmesi, potansiyel toksisite ve ila\u00e7 y\u00fckleme ile sal\u0131m kinetiklerinin hassas kontrol\u00fc, hen\u00fcz tam \u00e7\u00f6z\u00fcme kavu\u015fmam\u0131\u015f problemler aras\u0131ndad\u0131r. Bu nedenle laboratuvar bulgular\u0131n\u0131n klinik denemelerle desteklenmesi ve sa\u011flam verilerle ilerlenmesi ka\u00e7\u0131n\u0131lmazd\u0131r.<\/p>\n
Serviks kanserinin tedavisinde disiplinler aras\u0131 yakla\u015f\u0131m, t\u00fcm\u00f6r bask\u0131lama, anjiyogenez inhibisyonu ve yenilik\u00e7i analjezik stratejilerin entegre edildi\u011fi rejimlerin geli\u015ftirilmesini zorunlu k\u0131lmaktad\u0131r. Ki\u015fiselle\u015ftirilmi\u015f t\u0131p y\u00f6ntemleri ve nanoteknolojinin kullan\u0131lmas\u0131, hem t\u00fcm\u00f6r biyolojisinin hem de hastan\u0131n a\u011fr\u0131 profillerinin etkin bi\u00e7imde de\u011ferlendirilerek, tedavi ba\u015far\u0131s\u0131n\u0131 ve yan etki profilini optimize etmeyi m\u00fcmk\u00fcn k\u0131lmaktad\u0131r. Ak\u0131ll\u0131 ila\u00e7 ta\u015f\u0131y\u0131c\u0131 sistemlerinin t\u00fcm\u00f6r mikro\u00e7evresine duyarl\u0131l\u0131\u011f\u0131, yeni nesil tedavilerin hassasiyetini art\u0131rarak uygulanabilirli\u011fi y\u00fckseltmektedir.<\/p>\n
\u00d6zellikle kaynaklar\u0131n s\u0131n\u0131rl\u0131 oldu\u011fu \u00fclkelerde serviks kanserinin sosyal ve ekonomik y\u00fck\u00fc b\u00fcy\u00fckt\u00fcr. Bu nedenle tedavi modelleri eri\u015filebilirlik, etkinlik ve tolere edilebilirlik dengesi g\u00f6zetilerek olu\u015fturulmal\u0131d\u0131r. Psikoaktif olmayan kannabinoidler ve peptid destekli ila\u00e7 ta\u015f\u0131ma stratejileri, uygun altyap\u0131larla entegre edildi\u011finde \u00f6l\u00e7eklenebilir ve maliyet etkin \u00e7\u00f6z\u00fcmler sunabilir. Ara\u015ft\u0131rmac\u0131lar, klinisyenler, d\u00fczenleyici kurumlar ve hasta savunucular\u0131n\u0131n birlikte \u00e7al\u0131\u015fmas\u0131, laboratuvar bulgular\u0131n\u0131n halk sa\u011fl\u0131\u011f\u0131na d\u00f6n\u00fc\u015f\u00fcm\u00fcn\u00fc h\u0131zland\u0131racakt\u0131r.<\/p>\n
Genel olarak, son yay\u0131nlanan bu kapsaml\u0131 derleme, serviks kanserinde hem t\u00fcm\u00f6r biyolojisine y\u00f6nelik hem de hastalar\u0131n ya\u015fam kalitesini etkileyen a\u011fr\u0131 y\u00f6netimine y\u00f6nelik yenilik\u00e7i tedavi yakla\u015f\u0131mlar\u0131n\u0131 ortaya koyarak onkoloji alan\u0131nda yeni bir perspektif a\u00e7maktad\u0131r. Hem t\u00fcm\u00f6r b\u00fcy\u00fcmesini durduran hem de multidisipliner a\u011fr\u0131 kontrol\u00fcn\u00fc sa\u011flayan bu stratejiler, serviks kanserini kronik fakat y\u00f6netilebilir bir hastal\u0131\u011fa d\u00f6n\u00fc\u015ft\u00fcrme yolunda kritik bir a\u015famad\u0131r.<\/p>\n
Biofunctional Materials dergisinde yay\u0131mlanan bu inceleme, biyolojik aktif materyaller alan\u0131ndaki yenilikleri ve bunlar\u0131n klinik uygulamalara entegrasyonunu te\u015fvik etmektedir. Ayr\u0131ca dergi, 2025 sonuna dek g\u00f6nderilen makalelerde yay\u0131n \u00fccretini kald\u0131rarak bilimsel ilerlemenin desteklenmesini hedeflemektedir. Yak\u0131n gelecekte molek\u00fcler farmakoloji ile ileri biyomalzeme m\u00fchendisli\u011finin birle\u015fimi sayesinde, serviks kanseri tedavisinde hasta sonu\u00e7lar\u0131nda kayda de\u011fer iyile\u015fmeler ve s\u00fcrd\u00fcr\u00fclebilir, hedeflenmi\u015f tedavi modellerinin geli\u015fmesi beklenmektedir. Bu paradigmalar, d\u00fcnyada kad\u0131nlar aras\u0131nda en s\u0131k g\u00f6r\u00fclen ve \u00f6l\u00fcmc\u00fcl hastal\u0131klardan biri olan serviks kanserinin standart bak\u0131m\u0131n\u0131 temelden d\u00f6n\u00fc\u015ft\u00fcrmeye adayd\u0131r.<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Not applicable Kad\u0131nlarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcrlerinden biri olan serviks kanseri, d\u00fcnya genelinde y\u00fcz binlerce kad\u0131n\u0131 etkileyen ciddi bir sa\u011fl\u0131k sorunudur. Bu hastal\u0131k \u00f6zellikle d\u00fc\u015f\u00fck ve orta gelirli \u00fclkelerde daha yayg\u0131n g\u00f6r\u00fclmekte olup, bu b\u00f6lgelerde etkili tedaviye eri\u015fim s\u0131n\u0131rl\u0131 kalmaktad\u0131r. Geleneksel tedavi se\u00e7enekleri aras\u0131nda cerrahi operasyonlar, kemoterapi ve radyoterapi yer al\u0131rken, hastal\u0131\u011f\u0131n ilerlemesi ve beraberinde ortaya…<\/p>\n","protected":false},"author":1,"featured_media":5353,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[6758,6759,6761,6757,6760],"tmauthors":[],"class_list":{"0":"post-5352","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-cbd-ve-thc-kanser-tedavisi","9":"tag-kanser-agri-yonetimi-alternatif-yontemler","10":"tag-peptid-tedavileri-ve-kok-hucre-yaklasimlari","11":"tag-serviks-kanseri-anjiyogenezi","12":"tag-vegf-hedefli-serviks-kanseri-tedavileri"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/Rahatsizlik-Giderimi-Anjiyogenez-ve-Peptid-Tedavileri-1746807274.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5352"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5352\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5353"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5352"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMakale Ba\u015fl\u0131\u011f\u0131<\/strong>: Innovative therapeutic strategies for cervical cancer: advances in pain management, angiogenesis inhibition, and peptide-based therapies
\nHaberin Yay\u0131n Tarihi<\/strong>: 7-May-2025
\nWeb References<\/strong>: http:\/\/dx.doi.org\/10.55092\/bm20250008
\nDoi Referans<\/strong>: Odei-Mensah B, Adeyemi SA, Ngema LM, Mndlovu H, Choonara YE. Innovative therapeutic strategies for cervical cancer: advances in pain management, angiogenesis inhibition, and peptide-based therapies. Biofunct. Mater. 2025(3):0008
\nResim Credits<\/strong>: Beatrice Odei-Mensah, Samson A. Adeyemi, Lindokuhle M. Ngema, Hillary Mndlovu, Yahya E. Choonara; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
\nAnahtar Kelimeler<\/strong>: Cervical cancer, pain management, angiogenesis inhibition, cannabidiol, THC, cannabinoid receptor, peptide-based therapies, nanotechnology, tumor growth inhibition, cancer pain relief<\/p>\n","protected":false},"excerpt":{"rendered":"